Abstract:Plasma‐derived exosomes from patients with PD contain toxic α‐syn and PD‐exo downregulates lysosomal V1G1 expression; PD‐exo alternated the amount, morphology, and distribution of lysosomes in microglia and impaired the activity of hydrolytic enzymes in the lumen; PD‐exo augmented the accumulation of pathological α‐syn within microglia and induced NLRP3‐mediated neuroinflammation; and V1G1 deficiency impaired lysosomal function, leading to further aggregation of α‐syn in microglia and inflammation. Introduction Microglia are the main phagocytes in the brain and can induce neuroinflammation. Moreover, they are critical to alpha‐synuclein (α‐syn) aggregation and propagation. Plasma exosomes derived from patients diagnosed with Parkinson's disease (PD‐exo) reportedly evoked α‐syn aggregation and inflammation in microglia. In turn, microglia internalized and released exosomal α‐syn, enhancing α‐syn propagation. However, the specific mechanism through which PD‐exo influences α‐syn degradation remains unknown. Methods Exosomes were extracted from the plasma of patients with PD by differential ultracentrifugation, analyzed using electron microscopy (EM) and nanoparticle flow cytometry, and stereotaxically injected into the unilateral striatum of the mice. Transmission EM was employed to visualize lysosomes and autophagosomes in BV2 cells, and lysosome pH was measured with LysoSensor Yellow/Blue DND‐160. Cathepsin B and D, lysosomal‐associated membrane protein 1 (LAMP1), ATP6V1G1, tumor susceptibility gene 101 protein, calnexin, α‐syn, ionized calcium binding adaptor molecule 1, and NLR family pyrin domain containing 3 were evaluated using quantitative polymerase chain reaction or western blotting, and α‐syn, LAMP1, and ATP6V1G1 were also observed by immunofluorescence. Small interfering ribonucleic acid against V1G1 was transfected into BV2 cells and primary microglia using Lipofectamine® 3000. A PD mouse model was established via injection with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) into mice. A lentiviral‐mediated strategy to overexpress ATP6V1G1 in the brain of MPTP‐treated mice was employed. Motor coordination was assessed using rotarod and pole tests, and neurodegeneration in the mouse substantia nigra and striatum tissues was determined using immunofluorescence histochemical and western blotting of tyrosine hydroxylase. Results PD‐exo decreased the expression of V1G1, responsible for the acidification of intra‐ and extracellular milieu. This impairment of lysosomal acidification resulted in the accumulation of abnormally swollen lysosomes and decreased lysosomal enzyme activities, impairing lysosomal protein degradation and causing α‐syn accumulation. Additionally, V1G1 overexpression conferred the mice neuroprotection during MPTP exposure. Conclusion Pathogenic protein accumulation is a key feature of PD, and compromised V‐type ATPase dysfunction might participate in PD pathogenesis. Moreover, V1G1 overexpression protects against neuronal toxicity in an MPTP‐based PD mouse model, which may provide opportunities to develop novel therapeutic interventions for PD treatment.

The XK plasma membrane scramblase and the VPS13A cytosolic lipid transporter for ATP‐induced cell death

A partnership between the lipid scramblase XK and the lipid transfer protein VPS13A at the plasma membrane

Structure and function of the human apoptotic scramblase Xkr4

Cell Surface Translocation of Annexin A2 Facilitates Glutamate-induced Extracellular Proteolysis*

Caspase cleavage releases a nuclear protein fragment that stimulates phospholipid scrambling at the plasma membrane

Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome

NAD+ and ATP released from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells

Critical Role of Lipid Scramblase TMEM16F in Phosphatidylserine Exposure and Repair of Plasma Membrane after Pore Formation

Transient Receptor Potential Canonical 5-Scramblase Signaling Complex Mediates Neuronal Phosphatidylserine Externalization and Apoptosis

The role of the C-terminal tail region as a plug to regulate XKR8 lipid scramblase

P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke

Continued P2X7 Activation Leads to Mitochondrial Fission and Compromising Microglial Phagocytosis after Subarachnoid Haemorrhage.

Plasma exosomes impair microglial degradation of α‐synuclein through V‐ATPase subunit V1G1

A Novel Pathway of LPS Uptake Through Syndecan-1 Leading to Pyroptotic Cell Death

Giant Axon Formation in Mice Lacking Kell, XK, or Kell and XK

Deregulation of the actin cytoskeleton and macropinocytosis in response to phorbol ester by the mutant protein kinase C gamma that causes spinocerebellar ataxia type 14

Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin

Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3

Ablation of Vacuole Protein Sorting 18 (vps18) Gene Leads to Neurodegeneration and Impaired Neuronal Migration by Disrupting Multiple Vesicle Transport Pathways to Lysosomes

P2 × 7 Receptor Inhibits Astroglial Autophagy via Regulating FAK- and PHLPP1/2-Mediated AKT-S473 Phosphorylation Following Kainic Acid-Induced Seizures

Elimination of allosteric modulation of myocardial KATP channels by ATP and protons in two Kir6.2 polymorphisms found in sudden cardiac death.